Posted in | News | Gold | Copper | Silver | Mining Business

TomaGold Takes Major Step Towards Consolidating Chibougamau Mining Camp

TOMAGOLD CORPORATION (“TomaGold” or the “Corporation”) is pleased to announce that it has met all its initial commitments regarding the previously-announced acquisition of 20 mining properties (press releases dated August 14 and September 13), forming the major portion of the Chibougamau Mining Camp, in Quebec, Canada.

The Corporation has paid its initial commitments to SOQUEM Inc. (“SOQUEM”), Chibougamau Independent Mines Inc. (“CIM”) and Globex Mining Enterprises Inc. (“Globex”) to acquire a total of 13 mining properties by making cash payments totalling $340,000 and issuing a total of 7,125,000 common shares of TomaGold as per the agreements.

Furthermore, the Corporation has paid CIM an additional cash amount of $200,000 for the 6-month exclusivity right to acquire the 7 remaining properties, which will allow the Corporation to finalize its due diligence on those properties.

“Having met our commitments for the year for the major portion of the properties being acquired, this will allow us to focus on compiling the data on those properties to prepare for the next phases of exploration work, as project operators,” said David Grondin, President and CEO of TomaGold. “With these acquisitions, we have achieved a major step towards our goal of consolidating this promising and potentially mineral-rich mining camp.”

From 1955 to 2008, the Chibougamau Mining Camp produced around 55 million tonnes of ore corresponding to 994,802 tonnes of copper, 120 tonnes of gold, 102 tonnes of silver and 72,066 tonnes of zinc (Source: Géologie de la région de Chibougamau, EspaceINRS, November 28, 2018).

The common shares issued in relation with the agreements are subject to a resale restriction period of four months and one day.

The technical content of this press release has been reviewed and approved by André Jean, P.Eng., the Corporation’s Director of Exploration and a qualified person under National Instrument 43-101.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.